Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for preventing or treating rheumatoid arthritis comprising nasal inferior turbinate-derived mesenchymal stem cells as an active ingredient

Pharmaceutical composition for preventing or treating rheumatoid arthritis comprising nasal inferior turbinate-derived mesenchymal stem cells as an active ingredient

US Patent 11612620 · Granted Mar 28, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cytokines and use thereof2025
Cell selection apparatus and method2025
Human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted constru2025
Human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted constru2025
Human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted constru2025
Method for manufacturing mycelium mat into leather by using pH-controlled tannic2025
Battery module and energy storage device2025
Injectable composition containing prodrug of caspase inhibitors, and preparation2025
Actuator for driving reflector2025
Memory, memory system, operation method of the memory, and operation of the memo2024
Human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted constru2024
Human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted constru2024